Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: From sarcopenic obesity to cachexia

被引:281
|
作者
Biolo, Gianni [1 ]
Cederholm, Tommy [2 ]
Muscaritoli, Maurizio [3 ]
机构
[1] Univ Trieste, AOUTS, Dept Med Surg & Hlth Sci Clin Med, I-34127 Trieste, Italy
[2] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden
[3] Univ Roma La Sapienza, Dept Clin Med, I-00185 Rome, Italy
关键词
Sarcopenia; Cachexia; Sarcopenic obesity; Muscle metabolic dysfunction; Pre-cachexia; Muscle contractile dysfunction; RESTING ENERGY-EXPENDITURE; BODY-MASS INDEX; CHRONIC HEART-FAILURE; SKELETAL-MUSCLE; BED-REST; INSULIN-RESISTANCE; CANCER-PATIENTS; PROTEIN-METABOLISM; AMINO-ACID; NEOADJUVANT CHEMOTHERAPY;
D O I
10.1016/j.clnu.2014.03.007
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Skeletal muscle is the most abundant body tissue accounting for many physiological functions. However, muscle mass and functions are not routinely assessed. Sarcopenia is defined as skeletal muscle loss and dysfunction in aging and chronic diseases. Inactivity, inflammation, age-related factors, anorexia and unbalanced nutrition affect changes in skeletal muscle. Mechanisms are difficult to distinguish in individual subjects due to the multifactorial character of the condition. Sarcopenia includes both muscle loss and dysfunction which induce contractile impairment and metabolic and endocrine abnormalities, affecting whole-body metabolism and immune/inflammatory response. There are different metabolic trajectories for muscle loss versus fat changes in aging and chronic diseases. Appetite regulation and physical activity affect energy balance and changes in body fat mass. Appetite regulation by inflammatory mediators is poorly understood. In some patients, inflammation induces anorexia and fat loss in combination with sarcopenia. In others, appetite is maintained, despite activation of systemic inflammation, leading to sarcopenia with normal or increased BMI. Inactivity contributes to sarcopenia and increased fat tissue in aging and diseases. At the end of the metabolic trajectories, cachexia and sarcopenic obesity are paradigms of the two patient categories. Pre-cachexia and cachexia are observed in patients with cancer, chronic heart failure or liver cirrhosis. Sarcopenic obesity and sarcopenia with normal/increased BMI are observed in rheumatoid arthritis, breast cancer patients with adjuvant chemotherapy and in most of patients with COPD or chronic kidney disease. In these conditions, sarcopenia is a powerful prognostic factor for morbidity and mortality, independent of BMI. (C) 2014 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
引用
收藏
页码:737 / 748
页数:12
相关论文
共 19 条
  • [1] Muscle atrophy in aging and chronic diseases: is it sarcopenia or cachexia?
    Muscaritoli, Maurizio
    Lucia, Simone
    Molfino, Alessio
    Cederholm, Tommy
    Rossi Fanelli, Filippo
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2013, 8 (07) : 553 - 560
  • [2] Muscle atrophy in aging and chronic diseases: is it sarcopenia or cachexia?
    Maurizio Muscaritoli
    Simone Lucia
    Alessio Molfino
    Tommy Cederholm
    Filippo Rossi Fanelli
    [J]. Internal and Emergency Medicine, 2013, 8 : 553 - 560
  • [3] Sarcopenia and cachexia in chronic diseases: from mechanisms to treatment
    Lena, Alessia
    Hadzibegovic, Sara
    von Haehling, Stephan
    Springer, Jochen
    Coats, Andrew J. Stewart
    Anker, Markus S.
    [J]. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2021, 131 (12):
  • [4] Muscle mass adjustment method affects association of sarcopenia and sarcopenic obesity with metabolic syndrome
    Yilmaz, Ozlem
    Bahat, Gulistan
    [J]. GERIATRICS & GERONTOLOGY INTERNATIONAL, 2019, 19 (03) : 272 - 272
  • [5] Contractile dysfunction and altered metabolic profile of the aging rat thyroarytenoid muscle
    McMullen, CA
    Andrade, FH
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 2006, 100 (02) : 602 - 608
  • [6] MUSCLE STRENGTH, METABOLIC PROFILE, SARCOPENIA AND SARCOPENIC OBESITY IN OLDER CUBAN PEOPLE. PRELIMINARY RESULTS
    Ruiz-Alvarez, Vladimir
    Diaz-Sanchez, Maria Elena
    Hernandez-Triana, Manuel
    Llera-Abreu, Elisa
    Diaz-Fuentes, Yoandry
    Roque Treville, Celia Maria
    Lanyau Dominguez, Yeneisy
    Campos-Hernandez, Derbis
    Diaz-Dominguez, Maybe
    Hernandez-Hernandez, Hector
    [J]. ANNALS OF NUTRITION AND METABOLISM, 2017, 71 : 442 - 442
  • [7] Paravertebral Muscles as Indexes of Sarcopenia and Sarcopenic Obesity: Comparison With Imaging and Muscle Function Indexes and Impact on Cardiovascular and Metabolic Disorders
    Seo, Hyung Suk
    Lee, Hyeonbin
    Kim, Soriul
    Lee, Seung Ku
    Lee, Ki Yeol
    Kim, Nan Hee
    Shin, Chol
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2021, 216 (06) : 1596 - 1606
  • [8] Resveratrol Attenuates Obesity- and Aging-induced Sarcopenia Mitochondrial Dysfunction in Mice Skeletal Muscle
    Wu, Jia-Ping
    [J]. FASEB JOURNAL, 2020, 34
  • [9] Validity of estimating muscle and fat volume from a single MRI section in older adults with sarcopenia and sarcopenic obesity
    Yang, Y. X.
    Chong, M. S.
    Lim, W. S.
    Tay, L.
    Yew, S.
    Yeo, A.
    Tan, C. H.
    [J]. CLINICAL RADIOLOGY, 2017, 72 (05) : 427.e9 - 427.e14
  • [10] CONTRACTILE AND METABOLIC PROPERTIES OF LONGITUDINAL SMOOTH-MUSCLE FROM RAT URINARY-BLADDER AND THE EFFECTS OF AGING
    MUNRO, DD
    WENDT, IR
    [J]. JOURNAL OF UROLOGY, 1993, 150 (02): : 529 - 536